The Role of Microvascular Density (MVD) in Cervical Cancer: A Article Review
Abstract
Introduction: The development, invasion and metastasis process of cervical cancer is closely related to the ability of cancer cells in the process of tumor oxygenation and the process of angiogenesis. Angiogenesis plays a very important role in the growth, metastasis and progression of tumor cells. Microvascular Density (MVD) is an examination that counts the number of microvasculature compared to the area of tissue analyzed by histology and immunohistochemistry.
Method: This study reviewed literature by searching the Pubmed, ScienceDirect, and Cochran Library Database. The search query included “microvascular” and “cervical cancer”. The study was reviewed using the Preferred Reporting Item for Systemic Reviews and Meta-Analyses (PRISMA) standards. The scope of analysis was restricted to clinical trials conducted from 2011 to 2023
Result: Currently, MVD examination is an examination that is often carried out to evaluate the process of intratumor angiogenesis in cancer. By knowing the MVD value in cancer sufferers, it is hoped that it can be considered in determining therapy and assessing the outcome of the course of cervical cancer which can be considered as a prognostic factor. Apart from that, it can complement the theory of other biomolecular prognostic factors that play a role in cervical cancer such as vascular endothelial growth factor (VEGF), Ki-67 protein, p53 tumor suppressor gene, oxygenation factors, especially hypoxia inducible factors-1α (HIF-1α), enzymes protease (matrix metalloproteinase), and cell adhesion molecules (E-Kadherin, catenin).
Conclusion: The role of MVD in cervical cancer sufferers as an indicator of prognosis and success of therapy.
Peranan Kepadatan Mikrovaskuler (MVD) pada Kanker Serviks: Sebuah Ulasan Artikel
Abstrak
Pendahuluan: Proses perkembangan, invasi dan metastasis kanker serviks erat kaitannya dengan kemampuan sel kanker dalam proses oksigenasi tumor dan proses angiogenesis. Angiogenesis memainkan peran yang sangat penting dalam pertumbuhan, metastasis, dan perkembangan sel tumor. Kepadatan Mikrovaskular (MVD) merupakan pemeriksaan yang menghitung jumlah mikrovaskular dibandingkan dengan luas jaringan yang dianalisis secara histologi dan imunohistokimia.
Metode: Pencarian literatur dilakukan pada database PubMed dan ScienceDirect dan Cochrane Library. Pencarian dilakukan menggunakan istilah “mikrovaskular” dan “kanker serviks”. Penulisan sistematik review disesuaikan dengan pedoman Professed Reporting for Systematic Review and Meta-Analysis (PRISMA). Semua studi yang diinklusi merupakan uji klinis pada periode tahun 2011 – 2023.
Hasil: Saat ini MVD merupakan pemeriksaan yang sering dilakukan untuk mengevaluasi proses angiogenesis intratumor pada kanker. Dengan mengetahui nilai MVD pada penderita kanker diharapkan dapat menjadi pertimbangan dalam menentukan terapi dan menilai luaran perjalanan penyakit kanker serviks yang dapat diperhitungkan sebagai faktor prognosis. Selain itu dapat melengkapi teori faktor prognostik biomolekuler lain yang berperan dalam kanker serviks seperti faktor pertumbuhan endotel vaskular (VEGF), protein Ki-67, gen penekan tumor p53, faktor oksigenasi, terutama faktor pemicu hipoksia-1 α (HIF-1 α), enzim protease (matrix metalloproteinase), dan molekul adhesi sel (E-Kadherin, catenin).
Kesimpulan: MVD pada penderita kanker serviks berperan sebagai indikator prognosis dan keberhasilan terapi
Kata kunci: Kepadatan vaskular, kanker serviks, diagnosis
Keywords
Full Text:
PDFReferences
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May 4;71(3):209–49.
Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, et al. HPV Vaccination and the Risk of Invasive Cervical Cancer. New England Journal of Medicine. 2020 Oct 1;383(14):1340–8.
World Health Organization. Cervical Cancer. WHO . 2022.
Madeddu C, Sanna E, Nemolato S, Mulas O, Oppi S, Scartozzi M, et al. Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report. Diagnostics. 2022 Aug 7;12(8):1910.
Hattori S, Yoshikawa N, Mogi K, Yoshida K, Yoshihara M, Tamauchi S, et al. Significance of Concurrent Chemoradiotherapy as Primary Treatment in Patients with Metastatic Cervical Cancer. Current Oncology. 2021 Apr 29;28(3):1663–72.
Leek RD. The prognostic role of angiogenesis in breast cancer. Anticancer Res. 2001;21(6B):4325–31.
Jilaveanu LB, Puligandla M, Weiss SA, Wang XV, Zito C, Flaherty KT, et al. Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805. Clinical Cancer Research. 2018 Jan 1;24(1):217–23.
Naccarato AG, Viacava P, Bocci G, Fanelli G, Aretini P, Lonobile A, et al. Definition of the microvascular pattern of the normal human adult mammary gland. J Anat. 2003 Dec;203(6):599–603.
Weidner N, Semple JP, Welch WR, Folkman J. Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma. New England Journal of Medicine. 1991 Jan 3;324(1):1–8.
Hu X, Liu H, Ye M, Zhu X. Prognostic value of microvessel density in cervical cancer. Cancer Cell Int. 2018 Dec 3;18(1):152.
Winata IGS, Budiana ING, Jawi IM, Suwiyoga K. Neoadjuvant Chemotherapy in Stadium IB3, IIA2 and IIB Cervical Cancer a Narrative Review. Biomedical and Pharmacology Journal. 2022 Jun 30;15(2):901–10.
Andrijono. Kanker Serviks. 5th ed. Jakarta: Divisi Onkologi. Departemen Obstetri-Ginekologi. Fakultas Kedokteran Universitas Indonesia; 2016.
Callahan TL, Caughey AB. Blueprints Obstetrics & Gynecology. 2018.
Berek JS, Berek DL. Berek & Novak’s Gynecology. 2020.
Hoffman BL, Schorge JO, Bradshaw KD, Halvorson LM, Schaffer JI, Corton MM. Williams Gynecology. 2016.
Bielenberg DR, Zetter BR. The Contribution of Angiogenesis to the Process of Metastasis. The Cancer Journal. 2015 Jul;21(4):267–73.
Rajabi M, Mousa S. The Role of Angiogenesis in Cancer Treatment. Biomedicines. 2017 Jun 21;5(4):34.
Adair TH, Montani JP. Overview of Angiogenesis. 2010.
Jiang X, Wang J, Deng X, Xiong F, Zhang S, Gong Z, et al. The role of microenvironment in tumor angiogenesis. Journal of Experimental & Clinical Cancer Research. 2020 Dec 30;39(1):204.
Bożyk A, Wojas-Krawczyk K, Krawczyk P, Milanowski J. Tumor Microenvironment—A Short Review of Cellular and Interaction Diversity. Biology (Basel). 2022 Jun 18;11(6):929.
Zuazo-Gaztelu I, Casanovas O. Unraveling the Role of Angiogenesis in Cancer Ecosystems. Front Oncol. 2018 Jul 2;8.
Ribatti D. Judah Folkman, a pioneer in the study of angiogenesis. Angiogenesis. 2008 Mar 5;11(1):3–10.
O’byrne KJ, Dalgleish AG, Browning MJ, Steward WP, Harris AL. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease [Internet]. Available from: www.elsevier.com/locate/ejconline
Yang P, Chen N, Yang D, Crane J, Huang B, Dong R, et al. Cervical cancer cell–derived angiopoietins promote tumor progression. Tumor Biology. 2017 Jul 18;39(7):101042831771165.
Lin H, Huang CC, Ou YC, Huang EY, ChangChien CC, Tseng CW, et al. High Immunohistochemical Expression of TGF-β1 Predicts a Poor Prognosis in Cervical Cancer Patients who Harbor Enriched Endoglin Microvessel Density. International Journal of Gynecological Pathology. 2012 Sep;31(5):482–9.
Eka Bitaria Febrawati. Hubungan Microvessel Density (MVD) Berdasarkan Ekspresi Imunohistokimia Cluster of Differentiation 31 (CD31) dengan Klinikopatologi Karsinoma Payudara Invasif. [Medan]: Universitas Sumatera Utara; 2022.
Yulianti H, Hernowo BS. Hubungan Imunoekspresi CD34 dengan Gradasi dan Stadium (Duke) pada Adenokarsinoma Kolorektal. Majalah Kedokteran Bandung. 2013 Dec;45(4):240–4.
Simpson JF, Ahn C, Battifora H, Esteban JM. Endothelial area as a prognostic indicator for invasive breast carcinoma. Cancer. 1996 May 15;77(10):2077–85.
Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown AM. Application of Photoshop-based Image Analysis to Quantification of Hormone Receptor Expression in Breast Cancer. Journal of Histochemistry & Cytochemistry. 1997 Nov 26;45(11):1559–65.
Schoell WM, Pieber D, Reich O, Lahousen M, Janicek M, Guecer F, et al. Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis. Cancer. 1997 Dec 15;80(12):2257–62.
Barbareschi M, Gasparini G, Morelli L, Forti S, Dalla Palma P. Novel methods for the determination of the angiogenic activity of human tumors. Breast Cancer Res Treat. 1995;36(2):181–92.
Nico B, Benagiano V, Mangieri D, Maruotti N, Vacca A, Ribatti D. Evaluation of microvascular density in tumors: pro and contra. Histol Histopathol. 2008 May;23(5):601–7.
Szafarowski T, Sierdzinski J, Szczepanski MJ, Whiteside TL, Ludwig N, Krzeski A. Microvessel density in head and neck squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology. 2018 Jul 10;275(7):1845–51.
Yetkin-Arik B, Kastelein AW, Klaassen I, Jansen CHJR, Latul YP, Vittori M, et al. Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2021 Jan;1875(1):188446.
Zhu H, Luo H, Shen Z, Hu X, Sun L, Zhu X. Transforming growth factor-β1 in carcinogenesis, progression, and therapy in cervical cancer. Tumor Biology. 2016 Jun 24;37(6):7075–83.
Hu X, Liu H, Ye M, Zhu X. Prognostic value of microvessel density in cervical cancer. Cancer Cell Int. 2018 Dec 3;18(1):152.
Nico B, Benagiano V, Mangieri D, Maruotti N, Vacca A, Ribatti D. Review Evaluation of microvascular density in tumors: pro and contra Histology and Histopathology Cellular and Molecular Biology [Internet]. 2008. Available from: http://www.hh.um.es
Birner P, Schindl M, Obermair A, Breitenecker G, Kowalski H, Oberhuber G. Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int J Cancer. 2001 Jan 20;95(1):29–33.
Li W, Liang C, Liu P, Qi Y, Shen H, Li M, et al. Predictive value of microvessel features for the clinical response to neoadjuvant chemotherapy in cervical squamous carcinoma and the associations with prognosis. Transl Cancer Res. 2021 Jan;10(1):162–73.
Randall LM, Monk BJ, Darcy KM, Tian C, Burger RA, Liao SY, et al. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study. Gynecol Oncol. 2009 Mar;112(3):583–9.
Miyata Y, Mitsunari K, Asai A, Takehara K, Mochizuki Y, Sakai H. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy. Prostate. 2015 Jan 13;75(1):84–91.
Miyata Y, Sagara Y, Watanabe S ichi, Asai A, Matsuo T, Ohba K, et al. CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34. Virchows Archiv. 2013 Nov 25;463(5):673–9.
DOI: http://dx.doi.org/10.24198/obgynia.v7i3.720
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.